526 related articles for article (PubMed ID: 22571616)
21. Targeting heat shock proteins in metastatic castration-resistant prostate cancer.
Azad AA; Zoubeidi A; Gleave ME; Chi KN
Nat Rev Urol; 2015 Jan; 12(1):26-36. PubMed ID: 25512207
[TBL] [Abstract][Full Text] [Related]
22. Targeted disruption of hsf1 leads to lack of thermotolerance and defines tissue-specific regulation for stress-inducible Hsp molecular chaperones.
Zhang Y; Huang L; Zhang J; Moskophidis D; Mivechi NF
J Cell Biochem; 2002; 86(2):376-93. PubMed ID: 12112007
[TBL] [Abstract][Full Text] [Related]
23. Targeting heat shock proteins in prostate cancer.
Hessenkemper W; Baniahmad A
Curr Med Chem; 2013; 20(22):2731-40. PubMed ID: 23521679
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein 90: a unique chemotherapeutic target.
Cullinan SB; Whitesell L
Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
[TBL] [Abstract][Full Text] [Related]
25. The emerging role of CXC chemokines and their receptors in cancer.
Vinader V; Afarinkia K
Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
[TBL] [Abstract][Full Text] [Related]
26. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress.
Workman P; Burrows F; Neckers L; Rosen N
Ann N Y Acad Sci; 2007 Oct; 1113():202-16. PubMed ID: 17513464
[TBL] [Abstract][Full Text] [Related]
27. Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease.
Shrestha L; Bolaender A; Patel HJ; Taldone T
Curr Top Med Chem; 2016; 16(25):2753-64. PubMed ID: 27072696
[TBL] [Abstract][Full Text] [Related]
28. Heat shock proteins in human cancer.
Sarto C; Binz PA; Mocarelli P
Electrophoresis; 2000 Apr; 21(6):1218-26. PubMed ID: 10786894
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological intervention.
Reikvam H; Hatfield KJ; Ersvaer E; Hovland R; Skavland J; Gjertsen BT; Petersen K; Bruserud O
Br J Haematol; 2012 Feb; 156(4):468-80. PubMed ID: 22150087
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
Ban HS; Han TS; Hur K; Cho HS
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein gene expression and function in amphibian model systems.
Heikkila JJ
Comp Biochem Physiol A Mol Integr Physiol; 2010 May; 156(1):19-33. PubMed ID: 20138231
[TBL] [Abstract][Full Text] [Related]
32. Thermally induced injury and heat-shock protein expression in cells and tissues.
Rylander MN; Feng Y; Bass J; Diller KR
Ann N Y Acad Sci; 2005 Dec; 1066():222-42. PubMed ID: 16533928
[TBL] [Abstract][Full Text] [Related]
33. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology.
Feder ME; Hofmann GE
Annu Rev Physiol; 1999; 61():243-82. PubMed ID: 10099689
[TBL] [Abstract][Full Text] [Related]
34. Physiological adaptations of stressed fish to polluted environments: role of heat shock proteins.
Padmini E
Rev Environ Contam Toxicol; 2010; 206():1-27. PubMed ID: 20652666
[TBL] [Abstract][Full Text] [Related]
35. Molecular chaperones: toward new therapeutic tools.
Almeida MB; do Nascimento JL; Herculano AM; Crespo-López ME
Biomed Pharmacother; 2011 Jul; 65(4):239-43. PubMed ID: 21737228
[TBL] [Abstract][Full Text] [Related]
36. Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion.
Taha EA; Ono K; Eguchi T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533245
[TBL] [Abstract][Full Text] [Related]
37. Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.
Wang C; Zhang Y; Guo K; Wang N; Jin H; Liu Y; Qin W
Int J Cancer; 2016 Apr; 138(8):1824-34. PubMed ID: 26853533
[TBL] [Abstract][Full Text] [Related]
38. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
Kumalo HM; Bhakat S; Soliman ME
Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
[TBL] [Abstract][Full Text] [Related]
39. Inducers and co-inducers of molecular chaperones.
Ohtsuka K; Kawashima D; Gu Y; Saito K
Int J Hyperthermia; 2005 Dec; 21(8):703-11. PubMed ID: 16338852
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
Perego P; Cossa G; Zuco V; Zunino F
Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
